Dr. Basher M. Atiquzzaman, MD

Dr. Atiquzzaman practices at Greater Orlando Outpatient Center in Orlando, Florida.

Dr. Atiquzzaman's NPI, 1033159819, was assigned on June 8, 2006. Dr. Atiquzzaman graduated from Chittagong Medical College in 1992. Dr. Atiquzzaman holds Florida license ME89652.

Dr. Atiquzzaman's primary practice is Greater Orlando Outpatient Center, at 100 N Dean Rd, Orlando, FL 32825 in Orange County. The practice phone is (407) 963-0811.

Dr. Atiquzzaman's primary practice is Greater Orlando Outpatient Center in Orlando, Florida. Dr. Atiquzzaman is also affiliated with AdventHealth Orlando. The medical group on file is Orlando Health Medical Group. Dmand AI also links Dr. Atiquzzaman to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Atiquzzaman practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Atiquzzaman's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Atiquzzaman is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Atiquzzaman's licenses on file in 2 states: Florida and New York.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver and gastroduodenitis among the conditions Dr. Atiquzzaman treats.

CMS data shows 318 Medicare services from Dr. Atiquzzaman across 7 procedure codes in 2024, for 201 Medicare patients. Medicare paid $28,999 for them.

CMS counts 201 Medicare patients who saw Dr. Atiquzzaman in 2024. The largest group is 65 to 74, with 108 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.48, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Atiquzzaman's median patient age at 57, with 59% women.

In 2024, Dr. Atiquzzaman wrote 1,907 Medicare Part D claims for 1,064 patients. 72% of them were for generic drugs. CMS names the drug for 1,779 of them, across 24 drugs with 11 or more claims each, at $186,349 in total drug cost. In 2023, CMS named 1,172 claims across 24 drugs.

Dr. Atiquzzaman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 47 procedures of colonoscopy by Dr. Atiquzzaman, more than 62% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Atiquzzaman, published from 2018 to 2023. Dr. Atiquzzaman has published most often in Cureus. Dr. Atiquzzaman's most frequent co-authors are Saeed Ali, MD, Farid Gharagozloo, MD and Allan Gibofsky, MD.

CMS Open Payments shows 622 general payments to Dr. Atiquzzaman from 54 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 76% of the total. Madrigal Pharmaceuticals paid the most, $5,159. It also lists 1 research payment totaling $189 in 2025, naming 1 clinical trial.

Dr. Atiquzzaman graduated from Chittagong Medical College in 1992.

Dr. Atiquzzaman is in network with 17 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.